Please see this recent study conducted in Malawi and Mozambique evaluating the diagnostic value of urine LAM in HIV positive ambulatory patients with CD4 counts < 200 cells/uL. The findings of this study suggests that urine LAM is useful in a broader population than what it is currently recommended for, and can be expanded for use in patients who are less severely immunocompromised.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| WHO updates policy on Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV | 0 | 561 | November 4, 2019 | |
| Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV | 2 | 575 | June 21, 2019 | |
| Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study | 0 | 317 | December 17, 2022 | |
| Diagnostic accuracy of Fujifilm SILVAMP TB LAM test | 0 | 484 | May 5, 2020 | |
| Determine TB-LAM point-of-care tuberculosis assay in South Africa | 0 | 431 | August 11, 2020 |